Project 1 - COVID-19 Vaccinations Trend Analysis
COVID – 19
AIM
To reduce risks of getting a disease by working with your body’s natural defences to build protection. When you get a vaccine , your immune system responds. We fight against the dangerous virus, which is recently collapsed the world. The impact of the virus presence is made the history. The goal of a vaccine is to prime the immune response to adequately control the pathogen on natural infection and prevent disease manifestation.
INTRODUCTION
Coronaviruses are zoonotic. This means they first develop in animals before developing in humans. For the virus to pass from animal to humans, a person has to come into close contact with an animal that carries the infection. Once the virus develops in people, coronaviruses can be spread from person to person through respiratory droplets. This is a technical name for the wet stuff that moves through the air when you cough or sneeze. The viral material hangs out in these droplets and can be breathed into the respiratory tract (your windpipe and lungs), where the virus can then lead to an infection. 1 Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The virus that causes COVID-19 is mainly transmitted through droplets generated when an infected person coughs, sneezes, or exhales. These droplets are too heavy to hang in the air, and quickly fall on floors or surfaces. People can be infected by breathing in the virus if you are within close proximity of someone who has COVID-19, or by touching a contaminated surface and then your eyes, nose or mouth. Most people who fall sick with COVID-19 will experience mild to moderate symptoms and recover without special treatment.
Common symptoms:
- Fever.
- Tiredness.
- Dry cough.
Some people may experience:
- Aches and pains.
- Nasal congestion.
- Runny nose.
- Sore throat.
- Diarrhoea.
On average it takes 5–6 days from when someone is infected with the virus for symptoms to show, however it can take up to 14 days. Older people and people with certain health conditions have a higher risk for severe complications if they contract the virus. These health conditions include.
- lung conditions, such as COPD and asthma · certain heart conditions
- immune system conditions, such as HIV
- cancer that requires treatment
- severe obesity
- other health conditions, if not well-controlled, such as diabetes, kidney disease, or liver disease Pregnant women have a higher risk of complications from other viral infections, but it’s not yet known if this is the case for COVID-19. COVID-19 can be diagnosed similarly to other conditions caused by viral infections: using a blood, saliva, or tissue sample. However, most tests use a cotton swab to retrieve a sample from the inside nostrils. There’s currently no treatment specifically approved for COVID-19, and no cure for an infection, although treatments and vaccines are currently under study. Instead, treatment focuses on managing symptoms as the virus runs its course. Corona viruses like SARS and MERS are also treated by managing symptoms. In some cases, experimental treatments are tested to see how effective they are.
Examples of therapies used for these illnesses include:
- antiviral or retroviral medications
- breathing support, such as mechanical ventilation
- steroids to reduce lung swelling
- blood plasma transfusions
To prevent the spread of COVID-19:
- Avoid large events and mass gatherings.
- Avoid close contact (within about 6 feet, or 2 meters) with anyone who is sick or has symptoms.
- Stay home as much as possible and keep distance between yourself and others (within about 6 feet, or 2 meters) if COVID-19 is spreading in your community, especially if you have a higher risk of serious illness. Keep in mind some people may have COVID-19 and spread it to others, even if they don't have symptoms or don't know they have COVID-19.
- Wash your hands often with soap and water for at least 20 seconds, or use an alcohol-based hand sanitizer that contains at least 60% alcohol.
- Cover your face with a cloth face covering in public spaces, such as the grocery store, where it's difficult to avoid close contact with others, especially if you're in an area with ongoing community spread. Only use nonmedical cloth masks — surgical masks and N95 respirators should be reserved for health care providers.
- Cover your mouth and nose with your elbow or a tissue when you cough or sneeze. Throw away the used tissue.
- Avoid touching your eyes, nose and mouth.
- Avoid sharing dishes, glasses, bedding and other household items if you're sick.
- Clean and disinfect high-touch surfaces daily.
- Stay home from work, school and public areas if you're sick, unless you're going to get medical care. Avoid taking public transportation if you're sick
PROBLEM STATEMENT
A correlation study to assess the knowledge and self-expressed stigma regarding COVID-19 Outbreak among people in countries.
METHODOLOGY
RESEARCH METHODOLOGY
RESEARCH APPROACH
A descriptive, cross sectional study was used to assess the knowledge and self-expressed stigma regarding COVI19.
RESEARCH DESIGN
Non-experimental descriptive research is the label given to a study when a researcher cannot control, manipulate or alter the predictor variable or subjects, but instead, relies on interpretation, observation or interactions to come to a conclusion.
RESEARCH SETTING
The study will be conducted in selected areas of the world.
POPULATION
In this study population consist people who are living in different countries.
SAMPLE AND SAMPLING TECHNIQUE
In this study sample is people from selected areas of country. And non-probability Convenient Sampling Technique will be used.
SAMPLE SIZE
Total sample of 100 persons were selected.
Criteria for sample selection:
INCLUSION CRITERIA
- People18-55 years
- People who will be present at the time of study.
- Who can read and write English or Their national languages
DEVELOPMENT AND DESCRIPTION OF THE TOOL
Before developing the tool an extensive review of literature was done. Books and articles were also studied. Opinion and suggestion from various experts in the field and exposure of the investigator in the area of research were considered. The investigator selected the following tool for data collection. The tools were constructed according to the objective of the study it consists of three sections.
- Section I Demographic profile
- Section II To assess the knowledge regarding COVID-19 Outbreak among adults
- Section III To assess the self-expressed stigma regarding COVID-19 Outbreak among adults
PLAN FOR DATA ANALYSIS
The collected data was organized, tabulated and analyzed by using descriptive and inferential statistics methods wherever required. The descriptive statistics like percentage, mean, SD and inferential statistics like correlation and coefficient will be used. Further the analyzed data will be presented in the form of tables, figures and diagrams. Sample Size for Frequency in a Population.
SOURCES ,
https://rtc-planning.maps.arcgis.com/apps/dashboards/3b3a01c1d8444932ba075fb44b119b63
https://coronavirus.data.gov.uk/details/vaccinations
RECOMMENDATION
Some recommendations such as using big data with other emerging technologies to develop new COVID-19-fighting solutions, should be investigated. For example, Oracle cloud computing data analysis technologies were used to build a vaccine, a new vaccine candidate against the COVID-19 virus . Such type of idea should be addressed in future research and applications to aid stakeholders including governments, Mohs, hospitals, patients, and accountable authorities in making decisions and forecasting the future.
CONCLUSION
To ensure that every subsequent allocation strategy advances the intended public health objectives for COVID-19 vaccination: namely, to minimize morbidity and mortality loss, avoid economic harms from the pandemic, and narrow unfair health disparities, proactive preparation for the ethical distribution of vaccines toward COVID-19 is essential. There is no single method of prioritization that can successfully achieve all objectives. Instead, a multifaceted strategy should be enforced, considering the possibility of severe COVID-19 disease, instrumental importance, and transmission risk.
To deal with these challenges, big data is an effective tool for assisting in the prevention and management of risk in vaccine assignments. Governments should allow full use of big data in an outbreak situation in all areas of prevention and control, and they can use big data analytics to enhance the epidemic prevention process. Data collection systems for the Internet of Things, mobile devices, navigation and search engines, social media, and large-scale gene banks can all be completely developed in terms of knowledge collection.